Suchergebnisse - "Das, Anita F"

PubPharm (72)

1

Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Locke, J. | Pillar, C. | Castanheira, M. | +9

2

Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis : pooled data from two prospective randomised controlled trials

enthalten in: The Lancet. Infectious diseases | 2024

von Thompson, G. | Soriano, A. | Honore, P. | +14

3

Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis : A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Fowler, V. | Das, A. | Lipka-Diamond, J. | +13

4

Applying Desirability of Outcome Ranking End Points

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Dunne, M. | Aronin, S. | Das, A. | +5

5

Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Dunne, M. | Aronin, S. | Das, A. | +5

CommentOn: Clin Infect Dis. 2023 Feb 8;76(3):e1157-e1165. - PMID 36031403

6

Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019 : Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron

enthalten in: Open forum infectious diseases | 2023

von Ison, M. | Popejoy, M. | Evgeniev, N. | +58

7

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE) : a multicentre, double-blind, double-dummy, randomised phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Thompson, G. | Soriano, A. | Cornely, O. | +113

CommentIn: Lancet. 2023 Jan 7;401(10370):3-5. - PMID 36442483

8

Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis : A Phase 3, Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Dunne, M. | Aronin, S. | Das, A. | +4

9

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women : A Phase 3, Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Dunne, M. | Aronin, S. | Das, A. | +4

ErratumIn: Clin Infect Dis. 2023 Sep 18;77(6):937. - PMID 37590314

10

Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin

enthalten in: Journal of global antimicrobial resistance | 2022

von Paukner, S. | Goldberg, L. | Alexander, E. | +10

CommentIn: Future Microbiol. 2022 Apr;17:397-410. - PMID 35285291

1
2
3
4
5
6
7
8
Nächster »
[8]